C000010380 Holdings — Biotechnology Fund
All 75 reported holdings of Biotechnology Fund (C000010380) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| AbbVie Inc. | 7.46% | $796.23K |
| Amgen Inc. | 5.28% | $563.66K |
| Gilead Sciences Inc. | 5.00% | $533.79K |
| Vertex Pharmaceuticals Incorporated | 4.04% | $431.36K |
| Regeneron Pharmaceuticals, Inc. | 3.59% | $383.23K |
| Alnylam Pharmaceuticals Inc. | 2.63% | $280.58K |
| Insmed Inc | 2.48% | $264.25K |
| Beone Medicines Ltd. | 2.31% | $246.19K |
| Natera, Inc. | 2.11% | $225.59K |
| United Therapeutics Corporation | 2.09% | $222.96K |
| Biogen Inc | 2.03% | $216.33K |
| Royalty Pharma PLC | 2.00% | $213.13K |
| Illumina Inc | 1.75% | $187.23K |
| Revolution Medicines Inc | 1.71% | $181.95K |
| Moderna Inc | 1.66% | $177.44K |
| AstraZeneca PLC | 1.62% | $172.57K |
| Argenx SE | 1.62% | $172.34K |
| Incyte Corporation. | 1.57% | $167.44K |
| Viatris Inc | 1.51% | $161.62K |
| Bridgebio Pharma Inc | 1.49% | $158.47K |
| Alkermes PLC | 1.48% | $158.06K |
| Jazz Pharmaceuticals PLC | 1.48% | $157.48K |
| Neurocrine Biosciences Inc | 1.43% | $152.55K |
| Guardant Health Inc | 1.42% | $151.76K |
| Roivant Sciences Ltd | 1.42% | $150.97K |
| Ionis Pharmaceuticals, Inc. | 1.40% | $148.90K |
| Exelixis, Inc. | 1.30% | $138.83K |
| Medpace Holdings Inc. | 1.27% | $135.41K |
| Biomarin Pharmaceutical Inc. | 1.26% | $133.94K |
| Apellis Pharmaceuticals Inc | 1.24% | $131.83K |
| Arrowhead Pharmaceuticals Inc | 1.24% | $131.80K |
| Cytokinetics Inc | 1.19% | $126.61K |
| Vaxcyte Inc | 1.15% | $122.21K |
| CRISPR Therapeutics AG | 1.14% | $121.54K |
| Halozyme Therapeutics Inc | 1.10% | $117.04K |
| BioNTech SE | 1.07% | $114.48K |
| Axsome Therapeutics Inc. | 1.03% | $110.03K |
| Ascendis Pharma A/S | 1.02% | $108.88K |
| Cogent Biosciences, Inc. | 1.00% | $106.62K |
| Arcellx Inc | 1.00% | $106.55K |
| TG Therapeutics Inc | 0.97% | $103.88K |
| PTC Therapeutics, Inc. | 0.96% | $102.81K |
| Scholar Rock Holding Corp. | 0.95% | $101.42K |
| Madrigal Pharmaceuticals Inc | 0.91% | $97.37K |
| Mirum Pharmaceuticals Inc. | 0.90% | $96.35K |
| Protagonist Therapeutics Inc | 0.88% | $94.12K |
| Amicus Therapeutics Inc. | 0.82% | $87.93K |
| Rhythm Pharmaceuticals Inc | 0.79% | $84.27K |
| Apogee Therapeutics, Inc. | 0.76% | $80.97K |
| Kymera Therapeutics Inc | 0.73% | $77.38K |
| Twist Bioscience Corporation | 0.71% | $75.98K |
| Viking Therapeutics Inc. | 0.71% | $75.95K |
| Summit Therapeutics, Inc. | 0.70% | $74.38K |
| Nuvalent Inc | 0.69% | $73.97K |
| Acadia Pharmaceuticals Inc | 0.68% | $72.17K |
| Travere Therapeutics Inc | 0.67% | $71.66K |
| Sarepta Therapeutics Inc | 0.65% | $69.78K |
| Celcuity Inc. | 0.65% | $69.74K |
| Arcutis Biotherapeutics, Inc. | 0.65% | $69.34K |
| Veracyte Inc | 0.64% | $68.51K |
| Liquidia Corp. | 0.62% | $66.61K |
| Beam Therapeutics, Inc. | 0.57% | $60.60K |
| Ultragenyx Pharmaceuticals Inc | 0.53% | $56.86K |
| Praxis Precision Medicines Inc | 0.50% | $53.81K |
| GRAIL Inc | 0.50% | $52.87K |
| Soleno Therapeutics Inc | 0.49% | $52.46K |
| Recursion Pharmaceuticals Inc | 0.48% | $51.13K |
| Krystal Biotech Inc | 0.48% | $50.89K |
| Intellia Therapeutics Inc | 0.47% | $50.55K |
| Legend Biotech Corp. | 0.47% | $50.54K |
| Adma Biologics Inc | 0.44% | $47.14K |
| J.p. Morgan Securities LLC | 0.25% | $26.92K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.23% | $24.47K |
| Sanofi SA - Cvr | 0.00% | $0 |
| Akero Therapeutics Inc | 0.00% | $0 |
C000010380 overview: performance, fees, allocation and SEC filings